Carregant...
Current and future roles of biosimilars in oncology practice
Biologics have been used increasingly in the treatment and supportive care of cancer; however, their high cost places a significant burden on healthcare systems. The expiration of patents for biologics has led to the development of biosimilars, with the aim of reducing cost and increasing accessibil...
Guardat en:
| Publicat a: | Oncol Lett |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
D.A. Spandidos
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6923870/ https://ncbi.nlm.nih.gov/pubmed/31897113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.11105 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|